Rallybio RLYB
NASDAQ RLYB
$16.83 +0.23 (+1.39%)
As of: Aug 21, 2026 · 3:59 PM EDT

Rallybio (RLYB) Other Accumulated Expenses (2020 - 2023)

Rallybio (RLYB) posted Other Accumulated Expenses of $649000.0 for Q1 2023, down 0.76% sequentially from $654000.0 in Q4 2022, and down 1.67% YoY from $660000.0 in Q1 2022.

Rallybio (RLYB) Other Accumulated Expenses (2020 - 2023) Analysis & Trends

Rallybio has reported Other Accumulated Expenses for 4 years, with the latest figure at $649000.0 in Q1 2023.

  • Quarterly Other Accumulated Expenses fell 1.67% year-over-year to $649000.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $649000.0 (down 1.67% YoY) and the FY2022 annual result came in at $654000.0, down 66.24% from the prior year.
  • Other Accumulated Expenses retreated to $649000.0 in Q1 2023 per RLYB's latest filing, from $654000.0 in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $2.8 million in Q2 2022 and troughed at $112000.0 in Q4 2020.
  • A 4-year average of $888333.3 and a median of $649000.0 in 2023 frame the typical range for Other Accumulated Expenses.
  • The sharpest annual moves came in 2021 and 2022: Other Accumulated Expenses surged 1629.46% in 2021, then plunged 66.24% in 2022.
  • Over 4 years, Other Accumulated Expenses stood at $112000.0 in 2020, then soared by 1629.46% to $1.9 million in 2021, then tumbled by 66.24% to $654000.0 in 2022, then decreased by 0.76% to $649000.0 in 2023.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods registered $649000.0, $654000.0, and $419000.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Rallybio 94.61 Mn 94.61 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2023 649,000.00
Dec 31, 2022 654,000.00
Sep 30, 2022 419,000.00
Jun 30, 2022 2.85 Mn
Mar 31, 2022 660,000.00
Dec 31, 2021 1.94 Mn
Sep 30, 2021 303,000.00
Jun 30, 2021 414,000.00
Dec 31, 2020 112,000.00